Ocugen (OCGN) Stock Price, Quote, News & History | Benzinga

Ocugen Inc (OCGN) Stock Price, Quote, News & History

OCGNNASDAQ

Trade with Public

Trade with Public

$1.37

At close: Aug 28, 5:00 PM EST

$1.37

0.00010.01%

After Hours: 7:59 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 6.28M

Day Range

- - -

52 Wk Range

1.00 - 2.73

Market Cap

$464.62M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

30.17%

Days to Cover

23.89

Recent Ocugen, Inc. News

GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.

Avi Kapoor

Ocugen Eye Disease Gene Therapy Data Trails Earlier Results, Stocks Falls

Ocugen stock falls after Phase 2 OCU410 data for dry AMD trails interim results, despite lesion reduction.

Vandana Singh

Why Is Ocugen Stock Soaring Today?

Ocugen shares are surging Wednesday afternoon after Oppenheimer analyst Leland Gershell initiated coverage with an Outperform rating and a $10 price target.

Henry Khederian

Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving Higher On Wednesday

Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected earnings and raised sales guidance.

Avi Kapoor

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Top Wall Street analysts changed outlook on top names. For all analyst rating changes, see analyst ratings page. Analysts' thoughts on LGND stock.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-60.87M

Investing Cash Flow (TTM)

-148.00K

Financing Cash Flow (TTM)

133.86M

Free Cash Flow (TTM)

-61.02M

Capital Expenditure (TTM)

-153.00K

Net Change in Cash (TTM)

72.85M

Analyst Trends and Forecast

5

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$452.52M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

95.92

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-18.98%

Earnings Yield % (FWD)

-18.98%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.05

Company Debt

Total Debt

$84.11M

LT Debt

$1.73M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$32.74M

Total Cash

$100.05M

Debt to Equity

-

Issuance of Debt (TTM)

-$32.74M

Repayment of Debt (TTM)

-$32.74M

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 6.28M

Day Range

- - -

52 Wk Range

1.00 - 2.73

Market Cap

$464.62M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

30.17%

Days to Cover

23.89

About

Sector

Health Care

Industry

Biotechnology

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, No...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Ocugen (OCGN) stock?

A

You can purchase shares of Ocugen (NASDAQ:OCGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ocugen (OCGN) competitors?

A

Other companies in Ocugen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Ocugen (OCGN) stock?

A

Ocugen has a consensus price target of $7.33.

Q

What is the current price for Ocugen (OCGN)?

A

The stock price for Ocugen (NASDAQ: OCGN) is $1.3701 last updated August 27, 2026 at 7:59 PM EDT.

Q

Does Ocugen (OCGN) pay a dividend?

A

There are no upcoming dividends for Ocugen.

Q

When is Ocugen (NASDAQ:OCGN) reporting earnings?

A

Ocugen does not have any upcoming earnings scheduled.

Q

Is Ocugen (OCGN) going to split?

A

There is no upcoming split for Ocugen.

Q

What sector and industry does Ocugen (OCGN) operate in?

A

Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.